Revvity EBITDA 2010-2025 | RVTY
Revvity annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Revvity EBITDA for the quarter ending March 31, 2025 was $0.171B, a 11.13% increase year-over-year.
- Revvity EBITDA for the twelve months ending March 31, 2025 was $0.798B, a 12.93% increase year-over-year.
- Revvity 2024 annual EBITDA was $0.781B, a 5.54% increase from 2023.
- Revvity 2023 annual EBITDA was $0.74B, a 39.48% decline from 2022.
- Revvity 2022 annual EBITDA was $1.222B, a 24.08% decline from 2021.
| Revvity Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $781 |
| 2023 | $740 |
| 2022 | $1,222 |
| 2021 | $1,610 |
| 2020 | $1,074 |
| 2019 | $601 |
| 2018 | $527 |
| 2017 | $409 |
| 2016 | $397 |
| 2015 | $365 |
| 2014 | $279 |
| 2013 | $361 |
| 2012 | $237 |
| 2011 | $212 |
| 2010 | $249 |
| 2009 | $200 |
| Revvity Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $171 |
| 2024-12-31 | $225 |
| 2024-09-30 | $207 |
| 2024-06-30 | $195 |
| 2024-03-31 | $154 |
| 2023-12-31 | $184 |
| 2023-09-30 | $179 |
| 2023-06-30 | $189 |
| 2023-03-31 | $187 |
| 2022-12-31 | $243 |
| 2022-09-30 | $229 |
| 2022-06-30 | $360 |
| 2022-03-31 | $390 |
| 2021-12-31 | $399 |
| 2021-09-30 | $258 |
| 2021-06-30 | $411 |
| 2021-03-31 | $542 |
| 2020-12-31 | $419 |
| 2020-09-30 | $312 |
| 2020-06-30 | $236 |
| 2020-03-31 | $107 |
| 2019-12-31 | $205 |
| 2019-09-30 | $141 |
| 2019-06-30 | $151 |
| 2019-03-31 | $105 |
| 2018-12-31 | $165 |
| 2018-09-30 | $126 |
| 2018-06-30 | $142 |
| 2018-03-31 | $94 |
| 2017-12-31 | $126 |
| 2017-09-30 | $105 |
| 2017-06-30 | $102 |
| 2017-03-31 | $77 |
| 2016-12-31 | $118 |
| 2016-09-30 | $101 |
| 2016-06-30 | $92 |
| 2016-03-31 | $86 |
| 2015-12-31 | $72 |
| 2015-09-30 | $104 |
| 2015-06-30 | $98 |
| 2015-03-31 | $91 |
| 2014-12-31 | $11 |
| 2014-09-30 | $88 |
| 2014-06-30 | $99 |
| 2014-03-31 | $81 |
| 2013-12-31 | $129 |
| 2013-09-30 | $92 |
| 2013-06-30 | $73 |
| 2013-03-31 | $67 |
| 2012-12-31 | $5 |
| 2012-09-30 | $75 |
| 2012-06-30 | $83 |
| 2012-03-31 | $74 |
| 2011-12-31 | $14 |
| 2011-09-30 | $65 |
| 2011-06-30 | $67 |
| 2011-03-31 | $66 |
| 2010-12-31 | $76 |
| 2010-09-30 | $65 |
| 2010-06-30 | $57 |
| 2010-03-31 | $51 |
| 2009-12-31 | $55 |
| 2009-09-30 | $36 |
| 2009-06-30 | $61 |
| 2009-03-31 | $48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.220B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.134B | 27.29 |
| CVS Health (CVS) | United States | $76.787B | 9.54 |
| Elevance Health (ELV) | United States | $65.099B | 8.76 |
| Cencora (COR) | United States | $56.279B | 19.58 |
| DiDi Global (DIDIY) | China | $25.745B | 27.35 |
| Labcorp Holdings (LH) | United States | $22.177B | 17.50 |
| Natera (NTRA) | United States | $18.966B | 0.00 |
| BioMerieux (BMXMF) | France | $17.681B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.851B | 0.00 |
| ICON (ICLR) | Ireland | $15.102B | 14.53 |
| CochLear (CHEOY) | Australia | $13.402B | 0.00 |
| Solventum (SOLV) | United States | $12.933B | 13.69 |
| Medpace Holdings (MEDP) | United States | $12.571B | 33.27 |
| Viatris (VTRS) | United States | $11.044B | 3.79 |
| Avantor (AVTR) | United States | $9.683B | 14.07 |
| Sonic Healthcare (SKHHY) | Australia | $9.143B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.690B | 17.03 |
| HealthEquity (HQY) | United States | $8.305B | 36.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.515B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.066B | 29.83 |
| BrightSpring Health Services (BTSG) | United States | $3.609B | 33.11 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Surgery Partners (SGRY) | United States | $2.725B | 35.43 |
| Organon (OGN) | United States | $2.654B | 2.82 |
| Concentras Parent (CON) | United States | $2.520B | 14.56 |
| Alignment Healthcare (ALHC) | United States | $2.327B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.278B | 87.72 |
| Progyny (PGNY) | United States | $1.981B | 43.60 |
| GoodRx Holdings (GDRX) | United States | $1.786B | 35.71 |
| PACS (PACS) | United States | $1.782B | 0.00 |
| Premier (PINC) | United States | $1.744B | 13.23 |
| Ardent Health (ARDT) | United States | $1.582B | 6.74 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.080B | 8.22 |
| QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.853B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.758B | 7.10 |
| CareDx (CDNA) | United States | $0.712B | 11.12 |
| Embecta (EMBC) | United States | $0.686B | 4.62 |
| Nutex Health (NUTX) | United States | $0.528B | 7.99 |
| InnovAge Holding (INNV) | United States | $0.518B | 0.00 |
| Omada Health (OMDA) | $0.495B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.493B | 0.00 |
| LifeMD (LFMD) | United States | $0.486B | 0.00 |
| So-Young (SY) | China | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.12 |
| Oncology Institute (TOI) | United States | $0.328B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.284B | 0.00 |
| Beauty Health (SKIN) | United States | $0.226B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.192B | 0.00 |
| DocGo (DCGO) | United States | $0.149B | 24.33 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Biodesix (BDSX) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |